Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults.

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Liraglutide has been found to safely reduce BMI in children aged 6 to under 12, offering a potential new treatment for pediatric obesity. The obesity medication liraglutide was found to be safe and ...

A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...

For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication ...

These RCT findings support safety and efficacy in 6 to 12 year olds, but there are many unanswered questions, one expert says ...

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the ...

Liraglutide plus lifestyle intervention is efficacious for children aged 6 to <12 years with obesity, according to a study ...

While many consumers have hopped on the Ozempic bandwagon in recent months to help them lose weight, few studies have looked ...